| Publication Type: | Article |
| Journal Name: | Health Affairs |
| Full Citation: | Kesselheim, A., Darby, D., Studdert, D., Glynn, R., Levin, R., Avorn, J. "False Claims Act Prosecution Did Not Deter Off-Label Drug Use in the Case of Neurontin." Health Affairs, Dec 2011, 30(12): 2318-2327. |
| Project: | Sources of Transformative Innovation in Medication Development |
| People: | Aaron Kesselheim |